Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07143695

Parasternal Intercostal Muscle Thickening as an Additive Weaning Criterion

Parasternal Intercostal Muscle Thickening as an Additive Weaning Criterion to Minimize Re-intubation Rate: a Randomized Controlled Trial

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
200 (estimated)
Sponsor
Cairo University · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

Increased days of MV are not without hazards, including barotraumas and ventilator-associated pneumonia. Similarly, premature separation of MV is associated with increased mortality secondary to adverse cardiorespiratory events. Therefore, the time of weaning should be wisely evaluated. There is growing evidence concerning respiratory muscles dysfunction that contributes to difficulty or prolonged liberation from MV.

Detailed description

Researchers aim to evaluate the influence of adding parasternal thickening fraction to the standard weaning criteria and its impact on reintubation

Conditions

Interventions

TypeNameDescription
DEVICEParasternal intercostal thickening fractionParasternal intercostal thickening fraction less than 6.5%
DEVICESham parasternal intercostal thickeningUltrasound assessment only for purpose of blinding

Timeline

Start date
2025-09-01
Primary completion
2026-08-01
Completion
2026-08-31
First posted
2025-08-27
Last updated
2025-09-08

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT07143695. Inclusion in this directory is not an endorsement.